Christoph Lange Selected Research

Pulmonary Aspergillosis

2/2024	'Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference gold standard' - Author's reply.
12/2023	Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard.
1/2018	Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.
1/2016	Personalized Medicine for Chronic Respiratory Infectious Diseases: Tuberculosis, Nontuberculous Mycobacterial Pulmonary Diseases, and Chronic Pulmonary Aspergillosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph Lange Research Topics

Disease

77	Tuberculosis (Tuberculoses) 05/2024 - 11/2006
23	Infections 01/2023 - 03/2009
22	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 10/2023 - 12/2007
21	Asthma (Bronchial Asthma) 01/2023 - 12/2002
19	Chronic Obstructive Pulmonary Disease (COPD) 02/2023 - 08/2004
15	Extensively Drug-Resistant Tuberculosis 03/2024 - 12/2007
9	Pulmonary Tuberculosis 02/2024 - 11/2006
8	Latent Infection 10/2023 - 10/2012
7	COVID-19 11/2022 - 10/2020
5	Lung Diseases (Lung Disease) 01/2022 - 06/2009
4	Communicable Diseases (Infectious Diseases) 02/2024 - 08/2014
4	Pulmonary Aspergillosis 02/2024 - 01/2016
4	HIV Infections (HIV Infection) 11/2022 - 01/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2005
4	Neoplasms (Cancer) 07/2021 - 12/2010
3	Emphysema 02/2023 - 08/2011
3	Coinfection 01/2023 - 02/2013
3	Hypersensitivity (Allergy) 01/2023 - 02/2004
3	Respiratory Insufficiency (Respiratory Failure) 11/2022 - 01/2020
3	Persistent Infection 06/2009 - 01/2003
2	Sarcoidosis (Schaumann Disease) 02/2024 - 10/2009
2	Inflammation (Inflammations) 02/2024 - 02/2011
2	Latent Tuberculosis 07/2023 - 11/2022
2	Human Influenza (Influenza) 11/2022 - 10/2020
2	Respiratory Hypersensitivity 12/2019 - 11/2007
2	Heart Failure 01/2018 - 04/2009
2	Virus Diseases (Viral Diseases) 10/2015 - 01/2003
2	Schizophrenia (Dementia Praecox) 07/2015 - 06/2012
2	Rheumatoid Arthritis 11/2014 - 10/2013
2	Drug-Related Side Effects and Adverse Reactions 08/2014 - 07/2014
2	Obesity 10/2009 - 04/2006
1	Necrosis 04/2024
1	Pneumonia (Pneumonitis) 02/2024
1	Fibrosis (Cirrhosis) 02/2024

Drug/Important Bio-Agent (IBA)

17	InterferonsIBA 11/2022 - 10/2009
16	Rifampin (Rifampicin)FDA LinkGeneric 03/2024 - 01/2019
15	Tuberculin (PPD)IBA 02/2024 - 01/2008
13	bedaquiline (R207910)IBA 03/2024 - 04/2015
11	Biomarkers (Surrogate Marker)IBA 05/2024 - 08/2011
11	Proteins (Proteins, Gene)FDA Link 02/2023 - 03/2009
10	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 11/2003
10	VaccinesIBA 10/2023 - 10/2013
8	Linezolid (Zyvox)FDA Link 03/2024 - 10/2009
8	AntigensIBA 01/2017 - 08/2004
7	FluoroquinolonesIBA 03/2024 - 12/2007
7	EnzymesIBA 01/2018 - 11/2006
6	CytokinesIBA 02/2024 - 01/2014
6	Isoniazid (Ftivazide)FDA LinkGeneric 07/2023 - 10/2017
6	Bronchodilator Agents (Bronchodilators)IBA 02/2021 - 08/2003
5	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 12/2007
5	AcidsIBA 01/2020 - 11/2006
5	GoldIBA 01/2020 - 01/2008
5	Interleukin-2 (IL2)IBA 01/2017 - 07/2010
4	AntibodiesIBA 02/2024 - 07/2021
4	Messenger RNA (mRNA)IBA 01/2023 - 10/2009
4	Immunoglobulin E (IgE)IBA 01/2023 - 08/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2024 - 07/2005
3	Immunoglobulin G (IgG)IBA 02/2024 - 07/2021
3	pretomanidIBA 11/2023 - 04/2015
3	Meropenem (Merrem)FDA LinkGeneric 10/2023 - 01/2016
3	Pyrazinamide FDA LinkGeneric 07/2023 - 03/2015
3	Interferon-gamma (Interferon, gamma)IBA 02/2023 - 08/2003
3	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2005
3	Methacholine Chloride (Methacholine)FDA Link 12/2019 - 08/2003
3	InterleukinsIBA 01/2015 - 07/2010
2	Tumor Necrosis Factor InhibitorsIBA 04/2024 - 01/2014
2	rifapentine (Priftin)FDA Link 07/2023 - 01/2022
2	Genetic Markers (Genetic Marker)IBA 02/2023 - 08/2002
2	OPC-67683IBA 01/2023 - 04/2015
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2023 - 01/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2020 - 07/2007
2	Clofazimine (Lamprene)FDA Link 01/2019 - 01/2018
2	Nucleic AcidsIBA 01/2018 - 10/2009
2	GlucocorticoidsIBA 06/2017 - 09/2011
2	LactamsIBA 07/2016 - 03/2014
2	Apolipoproteins E (ApoE)IBA 10/2014 - 11/2008
2	SmokeIBA 04/2013 - 12/2009
2	nasIBA 02/2012 - 12/2009
2	Antiviral Agents (Antivirals)IBA 08/2004 - 01/2003
1	Janus Kinase InhibitorsIBA 04/2024
1	Janus KinasesIBA 04/2024
1	Activins (Activin)IBA 02/2024
1	activin AIBA 02/2024
1	AngiotensinsIBA 02/2024
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 02/2024
1	Drug CombinationsIBA 11/2023
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 10/2023
1	Ertapenem (Invanz)FDA Link 10/2023
1	Moxifloxacin (Avelox)FDA Link 07/2023
1	HLA-DM antigens (HLA-DMA)IBA 01/2023
1	S100A12 ProteinIBA 01/2023

Therapy/Procedure

31	Therapeutics 02/2024 - 09/2007
10	Drug Therapy (Chemotherapy) 07/2021 - 07/2010
6	Duration of Therapy 02/2024 - 08/2014
6	Precision Medicine 11/2022 - 01/2016
3	Art Therapy 11/2021 - 01/2018
3	Mechanical Ventilators (Ventilator) 01/2021 - 10/2017
3	Injections 01/2021 - 03/2015
2	Noninvasive Ventilation 01/2021 - 01/2020
2	Immunotherapy 12/2019 - 10/2015